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Abstract The retinal pigment epithelium (RPE) is separat-
ed from the photoreceptor outer segments by the subretinal
space. While the actual volume of this space is minimal, the
communication that occurs across this microenvironment is
important to the visual process, and accumulating evidence
suggests the purines ATP and adenosine contribute to this
communication. P1 and P2 receptors are localized to
membranes on both the photoreceptor outer segments and
on the apical membrane of the RPE which border subretinal
space. ATP is released across the apical membrane of the
RPE into this space in response to various triggers
including glutamate and chemical ischemia. This ATP is
dephosphorylated into adenosine by a series of ectoen-
zymes on the RPE apical membrane. Regulation of release
and ectoenzyme activity in response to light-sensitive
signals can alter the balance of purines in subretinal space,
and thus coordinate communication across subretinal space
with the visual process.
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Abbreviations
ADP adenosine diphosphate
AMP adenosine monophosphate
ATP adenosine triphosphate
ARL67156 6-N,N-diethyl-D-β,+-dibromomethylene ATP
BAPTA (1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-
tetraacetic acid)
bFGF basic fibroblast growth factor
CFTR cystic fibrosis transmembrane conductance
regulator
CGS21680 (2-[p-(2-carboxyethyl)phenylethylamino]-5′-
N-ethyl-carboxamidoadenosine
DCKA 5, 7-dichlorokynurenic acid
DMPA N(6)-[2-(3,5-dimethoxyphenyl)-2-(2-methyl-
phenyl)-ethyl]adenosine
EHNA erythro-9-(2-hydroxy-3-nonyl)adenine
hydrochloride
ENPP ectonucleotide pyrophosphatase/
phosphodiesterase
ERG electroretinogram
GPI glycosylphosphatidylinositol
MK-801 (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]
cyclohepten-5,10-imine maleate
NECA adenosine-5′-N-ethylcarboxamide
NMDA N-methyl-D-aspartic acid
NPPB 5-nitro-2-(3-phenylpropylamino)-benzoate
NTPDase ectonucleoside triphosphate
diphosphohydrolase
UDP uridine diphosphate
UTP uridine triphosphate
VEGF vascular endothelial growth factor
Introduction
The retinal pigment epithelium (RPE) lies between the
outer segments of the photoreceptors and the choroidal
blood supply (Fig. 1). The RPE combines the functions of
epithelial and glial cells, providing a barrier while also
supporting the neural photoreceptors and modulating their
function. Tight communication between photoreceptors and
the RPE is critical to coordinate the multiple levels of
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nication is becoming apparent. The relevance of this
purinergic input is emphasized by the many functional
effects of P1 and P2 receptor stimulation and by the
multiple mechanisms in place to regulate subretinal levels
of purine agonists. As the dynamics of ATP release and
extracellular conversion into adenosine will modify agonist
availability, the modulation of these processes can exert a
temporal control on purinergic signaling. The following
review will outline the main interactions between the RPE
and photoreceptors, describe the effects of stimulating
purinergic receptors on both sides of subretinal space, and
summarize how levels of ATP, ADP, and adenosine are
manipulated in this microenvironment.
Purines and subretinal space
RPE-photoreceptor interactions across the subretinal space
The outer segments of the rods and cones are responsible
for the initial stages of vision, converting photon energy
into a series of enzymatic reactions that close the light-
sensitive channels on the photoreceptor plasma membrane,
hyperpolarize the cells, and reduce the release of glutamate
from the synaptic terminals [1, 2]. Efficient photoreceptor
function depends upon both short-term and long-term
support from the RPE. The critical nature of these
interactions is evident from the rapid degeneration of
photoreceptors in the absence of a healthy RPE layer and
by the RPE localization of defective gene product in some
forms of hereditary photoreceptor degeneration [3].
The apical membrane of the RPE is separated from the
plasma membrane of the outer segments by an extracellular
space of only 10–20 nm [4]. Although small, this subretinal
space contains a highly structured matrix which ensheathes
the outer segments and extends to the RPE [5, 6]. The
presence of enzymes within this interphotoreceptor matrix
emphasizes that this extracellular space itself is functionally
active [7, 8]. This intimate anatomical relationship between
photoreceptors and the RPE reflects multiple functional
interactions. For example, the RPE accepts, recycles, and
exports central components of the phototransduction pro-
cess [9]. The outer segments are continuously resynthe-
sized, and the phagocytosis, degradation, and processing of
shed outer segment tips by the RPE cells is central to this
renewal [10]. The ion channels and transporters on the
apical membrane of the RPE help regulate the ionic
composition of the subretinal space [11]. As extracellular
levels of ions can modify the ionic driving forces across the
photoreceptor plasma membrane, these RPE transporters
can influence the state of neural activity. The transport of
fluid and ions from the apical membrane to basolateral
membrane of the RPE is also one of the main forces
keeping the retina attached [12].
The control of photoreceptor activity by light gives a
rapid temporal dependence to some interactions between
the photoreceptors and the RPE. The volume of subretinal
space increases in response to light [13], linking small
changes in the ionic composition of the subretinal space
with activity of the RPE transport mechanisms which
maintain this volume [14, 15]. Other processes are
controlled on a diurnal cycle. The shed tips of the outer
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Fig. 1 Schematic illustration of
the key components of purinergic
signaling in the subretinal micro-
environment. Stimulation of P2
receptors on the RPE can enhance
transepithelial fluid absorption
while P1 receptors can modulate
phagocytosis. ATP released
through CFTR and other Cl
−
channels can stimulate P2 recep-
tors or be converted to ADP, AMP,
and adenosine (Ado) by a series of
ectonucleotidases present on the
apical membrane of the RPE. By
controlling the balance of extra-
cellular purines available to stimu-
late these receptors these
mechanisms can control levels of
endogenous purines available to
activate the receptors. While theo-
retically possible, it remains to be
determined whether these subreti-
nal purines can actually stimulate
photoreceptors
102 Purinergic Signalling (2008) 4:101–107segments are phagocytosed by the RPE soon after the onset
of light [16, 17]. These processes can both be modulated by
purine levels in subretinal space, indicating purinergic
regulation is important over multiple time scales.
Purinergic receptors on photoreceptors
A2 adenosine receptors were localized to both the inner and
outer segments of photoreceptor outer segments over a
decade ago by Blazynski and colleagues [18], with more
recent reports emphasizing their functional role. A2 agonists
inhibit the L-type Ca
2+ channel on rod outer segments [19]
and can inhibit the synaptic release of glutamate from rods,
suggesting changes in adenosine levels in subretinal space
could modulate light sensitivity [20]. The A2 agonist
DPMA and the adenosine deaminase inhibitor EHNA
reduce mRNA for opsin in rods, suggesting that endoge-
nous levels of adenosine can downregulate opsin message
at night [21]. EHNA and the A2A receptor agonist
CGS21680 also increase the survival of chick embryonic
photoreceptors in culture [22], indicating a long-term
neuroprotective role for adenosine.
P2 receptors are also present in the photoreceptors. mRNA
for the P2X2 receptor is expressed in the photoreceptor cell
bodies, with immunohistochemical localization of the protein
to outer segments [23]. In situ hybridization indicates the
photoreceptor layer has the highest level of P2Y2 receptor of
any region in the rabbit retina, although staining was not
pronounced in monkey [24]. P2X7 receptors have recently
been localized to photoreceptor synaptic terminals, with
evidence for ecto-ATPase activity in the synapse, and
functional evidence suggesting ATP augments transmission
of the light response by rods [25]. It was suggested that ATP
might be co-released from photoreceptors with glutamate,
although this remains to be tested directly.
Purinergic receptors on the RPE
Stimulation of P1 receptors can have a considerable impact
on RPE cells. A2 receptors have been recognized on
cultured and fresh RPE cells for some time [26, 27], with
in situ hybridization confirming the presence of A2A
receptors in rat RPE [28]. Stimulation of A2 receptors
reduces the rate of rod outer segment phagocytosis by RPE
cells [29], while application of adenosine to the apical
membrane of chick RPE cells increases the basolateral Cl
-
conductance, the transepithelial potential, and the c-wave,
and decreases the hyperpolarization of the basal membrane
in response to light [30]. Although adenosine alone does
not increase intracellular Ca
2+ levels [31], adenosine acts
synergistically with ATP to elevate Ca
2+ levels in human
RPE cells by stimulating both A1 and A2A receptors [32,
33]. Stimulation of A1 receptors with high doses of NECA
increases the active transport of fluorescein across the RPE,
while activation of A2A receptors decreases this transport,
and by extension, transport of the ions that underlie fluid
movement [34]. Stimulation of A1 and A2A receptors
produces analogous increases and decreases, respectively,
in the absorption of subretinal fluid blebs. This is consistent
with the negative coupling of the A1 receptor and the
positive coupling of the A2 receptors to adenylate cyclase,
as increasing cAMP inhibits the transport of fluid across the
RPE towards the choroid [35–37]. The agonist 2-Cl
adenosine reverses the deficit in phosphoinositide metabo-
lism found in diabetic RPE cells [38], suggesting effects on
metabolism in addition to transport and phagocytosis.
Multiple P2 receptors have been localized to the RPE.
The P2Y2 receptor was initially characterized in cultured
human RPE [31], with subsequent reports localizing
transcript for P2Y1, P2Y2, P2Y4, and P2Y6 in the rat
RPE/choroid [39] and for P2Y1 and P2Y12 receptors in
ARPE-19 cells [40], and functionally identifying a P2X
receptor in rat RPE cells [41]. ATP, ADP, and UTP induce
numerous effects on RPE physiology [32, 33, 42, 43].
While these effects likely involve multiple different
receptor types, the contributions of the P2Y2 receptor have
been explored in most detail to date. The P2Y2 receptor has
been specifically localized to the apical membrane of fresh
bovine RPE cells, and addition of ATP to this membrane
transiently elevates Ca
2+, activates a basolateral Cl
- con-
ductance, inhibits an apical K
+ conductance, and increases
the apical to basolateral flow of fluid [43]. This increased
absorption of fluid from the subretinal space suggests P2Y2
receptor stimulation could reduce the excess fluid that
accumulates in retinal edemas, and several reports have
supported this theory. ATP, UTP, and the P2Y2 receptor
agonist INS37217 decrease the size of subretinal fluid blebs
when injected into subretinal space of rats [44]. In both
normal and rds +/- mice with experimentally induced
detachment, INS31217 improves the ERG recovery and
decreased cell death [45]. INS37217 also reduces subretinal
blebs in rabbits [46]. Injection of another P2Y2 agonist,
INS542, increases the active transport of fluorescein across
the RPE, consistent with this upregulation of ion and fluid
transport across the tissue [47]. Together these experiments
emphasize the clinical potential of treating retinal edema
with P2Y2 agonists.
Regulation of purine levels in subretinal space
While synthesized purinergic agonists may prove useful in
treating some ocular disorders, the endogenous activation
of P1 and P2 receptors in the subretinal microenvironment
will ultimately be determined by availability of agonists.
These levels are largely controlled by the release of ATP
into the subretinal space, its conversion into other purines
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enzymes or transporters. Recent work has increased our
understanding of both the stimuli that initiate changes in
subretinal purine levels and the mechanisms that mediate
these changes.
Release of ATP by the RPE
At least some of the ATP capable of stimulating the
purinergic receptors on RPE cells is released from the
RPE itself. The resulting autocrine stimulation ensures local
delivery, and control, of purines to initiate the physiologic
changes in the RPE. The release of ATP by RPE cells is
triggered by multiple stimuli including osmotic stress,
bFGF, UTP, NMDA, glutamate, and ATP [39, 40, 48–51].
The ATP release following activation of NMDA receptors
by glutamate may have the most interesting implications for
communication across subretinal space, given that gluta-
mate confers the light signal from photoreceptors to the rest
of the visual system. Glutamate and the specific receptor
agonist NMDA triggers ATP release from ARPE-19 cells,
with the release inhibited by NMDA antagonist MK-801,
and by DCKA, which inhibits the glycine B binding site on
NMDA receptors [51, 52]. Although NMDA raises intra-
cellular Ca
2+ levels, this increase is prevented by eliminat-
ing ATP with apyrase, indicating autostimulation through
released ATP is responsible for this Ca
2+ signal. NMDA
also triggers a release of ATP when applied to the intact
bovine RPE eyecup [51]. The NMDA receptors and the ATP
release sites have been functionally identified to the apical
membrane of the bovine RPE, suggesting the neurotransmit-
ter interactions could amplify the signal from any glutamate
reaching subretinal space.
TheabilityofbothUTPandATPtostimulatereleaseofATP
from the RPE supports the theory that the system acts to
amplify signals. When applied at greater than 1 μM, ATP
triggers a secondary release of ATP peaking 10 min after the
initial stimuli [40]. UTP also initiates a release in extracellular
ATP with a similar delay [48]. The rise in ATP triggered by
UTP is inhibited by the Cl
- channel blocker NPPB, and UDP
is much less effective at triggering release than UTP; both
observations suggest the P2Y2 receptor contributes to the
increase in ATP more than diphosphokinase, although
influence from the enzyme cannot be ruled out [53].
Recent evidence suggests that ischemia may lead to the
release of ATP from RPE cells. Chemical ischemia triggers
a substantial ATP release from cardiac myocytes [54], while
changes in oxygen levels trigger ATP release in central
chemoreceptors [55]. We found that exposure to sodium
cyanide led to a rapid release of ATP from ARPE-19 cells
(Fig. 2). As hypoxic and/or ischemic challenge may lead to
changes in the expression of growth factors in RPE cells
during certain ocular disorders such as macular
degeneration [56], and as purines can induce expression of
VEGF in other cells [57], this ATP release may contribute to
growth factor signaling by the diseased RPE.
The particular conduit for ATP release varies with the
stimuli. The release in response to hypotonic challenge is
largely dependent upon CFTR, as it was prevented by the
specific CFTR inhibitor CFTR172 in addition to the more
general blocker glybenclamide [50]. While the precise
mechanisms by which CFTR contributes to this release
are not yet known, a role for CFTR in ATP release into
subretinal space is consistent with the reduction of certain
ERG components in cftr -/- mice [58] and with the ability of
apical ATP to activate conductances associated with these
ERG components [43]. The release of ATP is also largely
blocked by the vesicular transport inhibitor brefeldin A,
suggesting the two processes occurred in series whereby
ATP efflux follows the insertion of vesicles containing
CFTR into the plasma membrane. Although the Ca
2+
chelator BAPTA blocks this ATP release [50], raising Ca
2+
alone with ionophore ionomycin does not itself initiate
release [48]. This necessary but not sufficient contribution of
Ca
2+ also supports a role for vesicular insertion.
In contrast to the release following hypotonic challenge,
the ATP release in response to NMDA does not involve
CFTR [51]. Release is blocked by NPPB, however,
suggesting another type of anion channel could serve as a
conduit for ATP release. The presence of parallel mecha-
nisms coexisting on the same cell for ATP release triggered
by either agonists or by cell swelling has also been reported
in astrocytes [59] and may reflect the multiple roles of
purinergic signaling within a given tissue. As both stimuli
lead to release across the apical membrane into subretinal
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Fig. 2 Chemical ischemia triggers ATP release from ARPE-19 cells.
ATP release was measured in the bath directly from cells plated in 96-
well plates to which the luciferin- luciferase reaction mixture was
added [51]. Left Levels of ATP in the bath after addition of 5 mM
NaCN to the cells. Measurement began 1 min after addition of NaCN
or control solution to wells. Right Levels of ATP measured at the
peak, 3 min after addition of NaCN (n=12). Levels were normalized
to concurrent levels in control (n=14). Symbols and bars represent
mean ± SE, *p<0.001
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microenvironment.
Interconversion of purines in subretinal space
The interconversion of nucleotides and nucleosides each
capable of stimulating distinct receptors makes the puriner-
gic signaling system of particular interest in a confined
region such as the subretinal space. The main enzymes
responsible for dephosphorylating extracellular ATP on the
RPE cells have been analyzed and a basic understanding of
their regulation has begun. This section first describes the
enzymes that act on ATP and ADP, followed by enzymes
which convert AMP into adenosine.
The dephosphorylation of extracellular ATP by RPE
cells involves enzymes from multiple families [40], as
found in airway epithelial cells [60]. Degradation of ATP
by the apical membrane of the fresh bovine eyecup and by
ARPE-19 cells is inhibited by ARL67156 or β+mATP.
Message for eNPP1, eNPP2, and eNPP3 is present in
ARPE-19 cells, consistent with the preference of β+mATP
for members of the eNPP family [61]. The cells also
express NTPDase2, and NTPDase3, although the intermit-
tent presence of NTPDase1 likely reflects a regulated
process [40]. Ecto-alkaline phosphatase has no effect on
ATP degradation in RPE cells, in contrast to its consider-
able contribution in airway epithelium [62]. The putative
contribution from diphosphokinases to interconversion of
subretinal purines is presently unknown.
Extracellular AMP is rapidly dephosphorylated into
adenosine in subretinal space. The production of adenosine
from ATP at the apical membrane of the bovine RPE
eyecup is inhibited by the ecto-5′-nucleotidase inhibitor
aβmADP, confirming a role for this enzyme [63]. The
enzyme is localized to rat RPE and ARPE-19 cells
immunohistochemically. Degradation of 5′AMP is highest
near the subretinal space of rat retina [63], although
localization in mouse indicated larger amounts of ecto-
5′-nucleotidase at the tips of adjacent Müller cells [64].
Levamisole does not inhibit the dephosphorylation of 5′
AMP by the RPE, consistent with the absence of substantial
ecto-alkaline phosphatase in subretinal space.
The presence of light may alter the levels of adenosine in
subretinal space. Epinephrine is released at the onset of
light [65] and stimulation of the RPE with epinephrine can
decrease activity of ecto-5′-nucleotidase [63]. While nor-
epinephrine and phenylephrine lead to similar decreases in
enzyme activity, prazosin and corynanthine block the
effects of norepinephrine, implicating the α1 epinephrine
receptor in the inhibition of ecto-5′-nucleotidase [63]. The
kinetics of inhibition are consistent with cleavage of the
nucleotidase from its GPI anchor. The phagocytosis of rod
outer segments is maximal shortly after light onset [16],
and this phagocytosis is inhibited by adenosine [29]. The
ability of epinephrine released by the illuminated retina to
reduce ecto-5′-nucleotidase activity and consequently aden-
osine levels may relieve this inhibition and enhance the rate
of phagocytosis at light onset.
Physiologic effects of subretinal purines on the RPE
and photoreceptors
The number of purinergic receptors on both photoreceptor
and RPE membranes suggests purines make multiple
contributions to the physiology of the outer retina. Our
increased understanding of how agonist levels in subretinal
space are controlled has begun to indicate how and when
this contribution may occur. Future research will involve
applying these findings from isolated systems to intact
RPE-photoreceptor models, and pursuing the role of
defective purinergic regulation in ocular disease. While it
is unlikely that ATP released across the apical membrane of
the RPE can diffuse to these P2 receptors in the outer
plexiform layer given the ecto-ATPase activity in the
synaptic clef [25], stimulation of receptors elsewhere on
the photoreceptor membrane is possible. It would be inte-
resting to determine whether ATP released from the RPE
and converted to adenosine by ecto-nucleotidases can
actually modulate the response to light by stimulating the
A2A receptors on photoreceptor outer segments. The impact
of purinergic signaling on chronic ocular diseases is also of
interest, such as the role of ischemia-driven ATP release in
VEGF production. While the small size of subretinal space
can complicate pharmacologic manipulation within the
intact RPE-photoreceptor complex, molecular approaches
may provide new insight into how endogenous purines in
subretinal space affect the physiology, and pathophysiolo-
gy, of both RPE and photoreceptors.
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